GANFORT

This brand name is authorized in Australia, Austria, Brazil, Croatia, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug GANFORT contains a combination of these active pharmaceutical ingredients (APIs):

1	Bimatoprost UNII QXS94885MZ - BIMATOPROST
	Bimatoprost is a potent ocular hypotensive agent. It is a synthetic prostamide, structurally related to prostaglandin F2α (PGF2α), that does not act through any known prostaglandin receptors.
	Read more about Bimatoprost
2	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED51	Timolol, combinations	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10107Y, 10108B, 5558M, 9464D
BR	Câmara de Regulação do Mercado de Medicamentos	501006301134319, 501006303171319, 501018100013603, 501018100013703, 501018100013803
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00265431, 00793360, 00793911, 06640172, 06640189, 06954002, 06954019, 09234998, 10738416, 10738422, 10744434, 11137392, 11218995, 11219003, 11282929, 11288010, 11288027, 11532220, 11532237, 12651636, 12801283, 13164743, 13352634, 13352640, 13651584, 13828195, 15621340, 16575926, 16992570, 16992587
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	362631012
EE	Ravimiamet	1252976, 1252987, 1713866, 1713877, 1713888
ES	Centro de información online de medicamentos de la AEMPS	06340001, 106340004
FI	Lääkealan turvallisuus- ja kehittämiskeskus	052405, 052414, 105470, 191091
FR	Base de données publique des médicaments	60892664, 66489175
GB	Medicines & Healthcare Products Regulatory Agency	104583, 104584, 142466, 161827, 185799, 232966, 374388, 375919, 377475, 389422
HK	Department of Health Drug Office	56429, 63183
IE	Health Products Regulatory Authority	15460, 27506, 27518, 27520
IL	מִשְׂרַד הַבְּרִיאוּת	6663
LT	Valstybinė vaistų kontrolės tarnyba	1005611, 1028637, 1071224, 1071225, 1071226
NL	Z-Index G-Standaard, PRK	106798, 81108
NZ	Medicines and Medical Devices Safety Authority	12264, 15688
PL	Rejestru Produktów Leczniczych	100160597
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51521001, W51521002
SG	Health Sciences Authority	13589P, 14966P
TN	Direction de la Pharmacie et du Médicament	3983021
TR	İlaç ve Tıbbi Cihaz Kurumu	8699490561126
ZA	Health Products Regulatory Authority	42/15.4/0127